Type / Class
Equity / Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share
Shares outstanding
266,837,198
Total 13F shares
18,088,058
Share change
+1,100,161
Total reported value
$569,233,000
Price per share
$31.47
Number of holders
32
Value change
+$34,027,507
Number of buys
12
Number of sells
21

Security key

05280R100

Report period

Q1 2019

Institutions

32

Top holders

10

Top shareholders of AUTL - Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Woodford Investment Management Ltd
13F
Company
4.5%
11,925,419
$391,631,000 31 Dec 2018
13F
Tetragon Partners GP Ltd
13F
Company
0.3%
800,000
$26,272,000 31 Dec 2018
13F
Alphabet Inc.
13F
Company
0.27%
714,072
$23,450,000 31 Dec 2018
13F
Capital World Investors
13F
Company
0.23%
611,112
$20,069,000 31 Dec 2018
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.19%
501,540
$16,471,000 31 Dec 2018
13F
Capital International Investors
13F
Company
0.18%
488,888
$16,055,000 31 Dec 2018
13F
Artal Group S.A.
13F
Company
0.18%
475,000
$15,599,000 31 Dec 2018
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
0.09%
235,576
$7,736,000 31 Dec 2018
13F
SPHERA FUNDS MANAGEMENT LTD.
13F
Company
0.08%
202,994
$6,666,000 31 Dec 2018
13F
BlackRock Finance, Inc.
13F
Company
0.08%
202,973
$6,666,000 31 Dec 2018
13F
BAKER BROS. ADVISORS LP
13F
Company
0.06%
156,773
$5,148,000 31 Dec 2018
13F
MARSHALL WACE, LLP
13F
Company
0.05%
120,442
$3,955,000 31 Dec 2018
13F
JENNISON ASSOCIATES LLC
13F
Company
0.04%
106,971
$3,513,000 31 Dec 2018
13F
Granahan Investment Management, LLC
13F
Company
0.04%
96,450
$3,167,000 31 Dec 2018
13F
FEDERATED HERMES, INC.
13F
Company
0.02%
49,260
$1,618,000 31 Dec 2018
13F
OXFORD ASSET MANAGEMENT LLP
13F
Company
0.02%
48,672
$1,598,000 31 Dec 2018
13F
Allianz Asset Management GmbH
13F
Company
0.02%
45,860
$1,480,000 31 Dec 2018
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0.02%
42,700
$1,402,000 31 Dec 2018
13F
Nuveen Asset Management, LLC
13F
Company
0.01%
28,267
$928,000 31 Dec 2018
13F
Weiss Multi-Strategy Advisers LLC
13F
Company
0.01%
27,000
$887,000 31 Dec 2018
13F
BLAIR WILLIAM & CO/IL
13F
Company
0.01%
21,600
$709,000 31 Dec 2018
13F
BANK OF MONTREAL /CAN/
13F
Company
0%
12,000
$394,000 31 Dec 2018
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0%
11,700
$384,000 31 Dec 2018
13F
TD ASSET MANAGEMENT INC
13F
Company
0%
10,149
$333,000 31 Dec 2018
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0%
9,811
$322,000 31 Dec 2018
13F
VIRTUS ADVISERS, LLC
13F
Company
0%
9,502
$312,000 31 Dec 2018
13F
BOOTHBAY FUND MANAGEMENT, LLC
13F
Company
0%
8,000
$263,000 31 Dec 2018
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0%
6,812
$224,000 31 Dec 2018
13F
GOLDMAN SACHS GROUP INC
13F
Company
0%
6,694
$220,000 31 Dec 2018
13F
ProShare Advisors LLC
13F
Company
0%
6,121
$201,000 31 Dec 2018
13F
BARCLAYS PLC
13F
Company
0%
3,461
$113,000 31 Dec 2018
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
948
$31,000 31 Dec 2018
13F
UBS Group AG
13F
Company
0%
884
$29,000 31 Dec 2018
13F
WELLS FARGO & COMPANY/MN
13F
Company
0%
550
$18,000 31 Dec 2018
13F
PRELUDE CAPITAL MANAGEMENT, LLC
13F
Company
0%
394
$13,000 31 Dec 2018
13F
Daiwa Securities Group Inc.
13F
Company
0%
200
$7,000 31 Dec 2018
13F
IFP Advisors, Inc
13F
Company
0%
50
$2,000 31 Dec 2018
13F
Legal & General Group Plc
13F
Company
0%
46
$1,000 31 Dec 2018
13F

Institutional Holders of Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL) as of Q1 2019

As of 31 Mar 2019, Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL) was held by 32 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,088,058 shares. The largest 10 holders included Woodford Investment Management Ltd, Polygon Management Ltd., Cormorant Asset Management, LP, Alphabet Inc., Capital World Investors, PRICE T ROWE ASSOCIATES INC /MD/, Capital International Investors, MILLENNIUM MANAGEMENT LLC, Artal Group S.A., and MARSHALL WACE, LLP. This page lists 32 institutional shareholders reporting positions in this security for the Q1 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2019 vs Q4 2018 Across Filers

Q4 2018 holders
36
Q1 2019 holders
32
Holder diff
-4
Investor Q4 2018 Shares Q1 2019 Shares Share Diff Share Chg % Q4 2018 Value $ Q1 2019 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .